VentriPoint Diagnostics (CVE:VPT) Shares Down 14.7% – What’s Next?

by · The Cerbat Gem

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was down 14.7% on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares were traded during trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Stock Performance

The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The company has a market cap of C$23.52 million, a P/E ratio of -4.48 and a beta of 0.39. The company’s 50-day moving average price is C$0.10 and its two-hundred day moving average price is C$0.13.

About VentriPoint Diagnostics

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Featured Stories